Background: The escalating morbidity and mortality of chronic obstructive pulmonary disease (COPD) necessitates improved diagnostic approaches for comorbid infections. COPD patients exhibit heightened susceptibility to opportunistic pathogens like Nocardia species due to compromised airway defenses and frequent glucocorticoid/immuno-suppressant use. Despite its clinical significance, Nocardia infection remains diagnostically challenging due to nonspecific presentations and imaging features.
Objectives: To develop and validate a diagnostic model integrating clinical characteristics and risk factors for COPD complicated by Nocardia infection.
Design: A retrospective analysis was conducted on clinical data from 586 patients diagnosed with COPD and Nocardia infection, including clinical symptoms, laboratory tests, imaging findings, and treatment outcomes. Patients were screened according to inclusion and exclusion criteria and divided into two groups: COPD with Nocardia infection group (infection group) and COPD-only group (control group).
Methods: This retrospective study analyzed 586 COPD patients (2019-2024), stratified into Nocardia-infected (n = 289) and noninfected (n = 297) cohorts. Demographic, laboratory, pulmonary function, and imaging data were collected. Multivariate logistic regression identified independent predictors, which informed a nomogram model. Model performance was assessed via concordance index (C-index), calibration curves, and ROC analysis.
Results: Independent risk factors included hemoptysis (OR = 1.99, 95% CI: 0.76-5.26), lymphocyte count (OR = 6.81, 95% CI: 4.06-11.42), hemoglobin (OR = 1.01, 95% CI: 0.99-1.03), and pulmonary function parameters (FEV₁/FVC ratio OR = 12.47, 95% CI: 1.25-124.16). The model demonstrated excellent discrimination (C-index: 0.895 infected, 0.829 noninfected) and calibration (mean absolute error: 0.127-0.170). ROC analysis revealed AUCs of 0.896 (95% CI: 0.90-0.97) and 0.830 (95% CI: 0.77-0.89) for infected and noninfected groups, respectively.
Conclusion: This validated nomogram provides a clinically actionable tool for early Nocardia detection in COPD patients, addressing a critical diagnostic gap. External validation is warranted to confirm generalizability.
Keywords: COPD; diagnostic modeling; nocardiosis; pulmonary infection risk stratification.
Understanding and predicting Nocardia infection in COPD patients: a study based on key symptoms and test resultsThis study developed a tool to predict Nocardia infection in COPD patients using key risk factors like coughing blood and poor lung function, aiding early diagnosis. Further validation is needed. Why was the study done? COPD patients have weakened immune systems and often use medications like steroids, making them more likely to get infections. One rare but dangerous infection is caused by Nocardia, which is hard to diagnose because its symptoms (like cough and fever) look like other lung problems. Doctors often miss it or treat it too late, which can be life-threatening. This study aimed to create a simple tool to help doctors spot Nocardia infection early in COPD patients, so they can start treatment faster. What did the researchers do? The researchers studied COPD patients to identify factors that increase the risk of a rare but serious infection called Nocardia. They developed a tool to help doctors diagnose this infection earlier. What did the researchers find? They found that symptoms like coughing up blood, low immune cell counts, poor lung function, and certain blood test results were strong indicators of Nocardia infection. A model based on these factors accurately predicted the infection risk. What do the findings mean? This tool can help doctors detect Nocardia infection sooner in COPD patients, leading to faster treatment and better outcomes. More testing in different hospitals is needed to ensure the tool works for all patients.